$25.37
-0.0975-0.38%
At close: Sep 18, 5:00 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Amplify Weight Loss Drug & Treatment ETF (THNR) Stock Price, Quote, News & History
THNRARCA
Amplify Weight Loss Drug & Treatment ETF (THNR) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
5.85M
Fund Score
Loading...
Key Statistics
Open
$25.72
High
$25.72
52 Wk High
$27.94
AUM
5.85M
Dividend
$0.41
Ex-Div Date
Dec 30, 2025
Volume
860
Market Cap
$231.58B
Mgmt Fee
0.59%
P/E Ratio
33.18
Prev. Close
$25.46
Low
$25.29
52 Wk Low
$22.63
Shares Out
200.00K
Yield
1.63%
Div. Freq
-
Avg. Volume Daily
1.76K
Beta
0.39
Avg. Expense Ratio
0.59%
P/B Ratio
5.51
Recent Amplify Weight Loss Drug & Treatment ETF News
FAQ
Q
How do I buy Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
You can purchase shares of Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.
Q
Who are Amplify Weight Loss Drug & Treatment ETF (THNR) competitors?
A
There are no as such competitors for Amplify Weight Loss Drug & Treatment ETF.
Q
What is the forecast, or price target, for Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
There is no analysis for Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.
Q
What is the current price for Amplify Weight Loss Drug & Treatment ETF (THNR)?
A
The stock price for Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $25.3662 last updated September 18, 2026 at 8:00 PM EDT.
Q
Does Amplify Weight Loss Drug & Treatment ETF (THNR) pay a dividend?
A
There are no upcoming dividends for Amplify Weight Loss Drug & Treatment ETF.
Q
When is Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) reporting earnings?
A
Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.
Q
Is Amplify Weight Loss Drug & Treatment ETF (THNR) going to split?
A
There is no upcoming split for Amplify Weight Loss Drug & Treatment ETF.
Key Statistics
Open
$25.72
High
$25.72
52 Wk High
$27.94
AUM
5.85M
Dividend
$0.41
Ex-Div Date
Dec 30, 2025
Volume
860
Market Cap
$231.58B
Mgmt Fee
0.59%
P/E Ratio
33.18
Prev. Close
$25.46
Low
$25.29
52 Wk Low
$22.63
Shares Out
200.00K
Yield
1.63%
Div. Freq
-
Avg. Volume Daily
1.76K
Beta
0.39
Avg. Expense Ratio
0.59%
P/B Ratio
5.51
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | May 21, 2024 |
| Managers | Dustin Lewellyn Ernesto Tong |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The Index is comprised of global companies expected to economically benefit from weight loss drug development. The Index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved